13 Insights on

• Improved Tolerability
• Good Tolerability
• Reduced Immunogenicity
• Altered Enteric Bacterial Flora
• Enhanced Immunogenicity
• Increased Safety
• Well Tolerated Probiotic
• Increased Safety of Probiotic Use
• Enhanced Immune Response to Oral Inactivated Cholera Vaccine
• Post-Vaccinal Immunostimulatory Effect
• Improved Tolerability of Bifidobacterium breve BBG-01
• Enhanced Immunogenicity of Cholera Vaccine
• Increased Safety in Children

3 Insights on

• Reduced Helicobacter pylori Colonization
• Improved Digestive Health
• Reduced Gastric Tissue Damage

7 Insights on

• Increased Antioxidant Activity
• Enhanced Antioxidant Activity
• Increased Antibiotic Susceptibility
• Improved Free Radical Scavenging Activity
• Reduced Epinephrine Autoxidation
• Reduced Physical Activity
• Increased Mucus Binding Capacity

1 Insight on

• Reduced Staphylococcus Aureus Virulence

5 Insights on

• Reduced Total Cholesterol Levels
• Enhanced Antimicrobial Resistance
• Improved Intestinal Cell Adhesion
• Improved Gastrointestinal Survival
• Increased Intestinal Cell Adherence

2 Insights on

• Reduced Feeding Intolerance
• Incidence of Death

4 Insights on

• Improved Atopic Dermatitis Severity
• Reduced Atopic Dermatitis Severity
• Increased Fecal Bifidobacterium lactis Levels
• Improved Atopic Eczema

4 Insights on

• Increased Antioxidant Activity
• Improved Immunomodulation
• Reduced Hypertension
• Reduced Angiotensin I-Converting Enzyme Activity

1 Insight on

• Increased CSF3 Output in Placental Trophoblast Cells

6 Insights on

• Increased Beneficial Gut Microbiota
• Increased Salmonella Shedding
• Post-Infection Compensatory Weight Gain
• Increased Beneficial Gut Bacteria
• Improved Growth
• Increased Fecal Salmonella Shedding During Infection

18 Insights on

• Reduced Total Cholesterol Levels
• Reduced Low-Density Lipoprotein Level
• Reduced Body Weight
• Improved Weight Management
• Increased HDL Cholesterol Levels
• Reduced LDL Cholesterol
• Improved Lipid Profile
• Reduced Serum Total Cholesterol Levels
• Reduced Serum Triglyceride Levels
• Stable High-Density Lipoprotein Cholesterol Level
• Reduced Atherogenic Index
• Enhanced Antimicrobial Resistance
• Reduced Serum Total Cholesterol
• Reduced Bacterial Translocation
• Reduced Pathogen Activity
• Maintained High-Density Lipoprotein Levels
• Reduced Low-Density Lipoprotein Cholesterol
• Reduced Liver Weight-to-Body Weight Ratio

13 Insights on

• Reduced Anxiety Levels
• Reduced Psychological Distress
• Improved Coping Strategies
• Reduced Stress Hormone Levels
• Reduced Anxiety Symptoms
• Reduced Subjective Stress Levels
• Reduced Anxiety
• Improved Problem-Solving Skills
• Reduced Urinary Free Cortisol Levels
• Reduced Cortisol Levels
• Improved Psychological Distress
• Reduced HADS Global Score
• Reduced Anxiety-like Behavior

9 Insights on

• Increased Body Weight
• Improved Immune Response
• Reduced Inflammation Levels
• Increased Dendritic Cell Activation
• Reduced Inflammation
• Increased Weight Gain Post-Challenge
• Reduced Cumulative Morbidity Rates
• Increased Helper T Cell Activation
• Enhanced Antibody Production

2 Insights on

• Reduced Pathogen Growth
• Reduced Pathogen Adhesion

4 Insights on

• Reduced Gastrointestinal Symptoms
• Reduced Acute Otitis Media
• Reduced Respiratory Infections
• Increased Antibiotic Use

5 Insights on

• Improved Atopic Dermatitis Symptoms
• Altered TH1/TH2 Immune Response
• Reduced Topical Steroid Usage
• Reduced Atopic Dermatitis Severity
• Reduced Atopic Dermatitis Medication Use

6 Insights on

• Reduced IgE Production
• Increased Regulatory T Cell Count
• Reduced Th2 Cytokine Production
• Enhanced Cytokine Production
• Reduced Activated B Cells
• Downregulated Complement System Activity

2 Insights on

• Unchanged Insulin Sensitivity
• Stable Systemic Inflammatory Response

2 Insights on

• Increased Interleukin-10 Levels
• Increased Interferon Beta Levels

1 Insight on

• Improved Oxidative Stress Resistance

22 Insights on

• Increased Fecal Lactobacilli
• Reduced Crying Duration
• Stable Body Weight
• Reduced Ammonia Levels
• No Adverse Events Observed
• Reduced Crying in Infants
• Increased Response Rate
• Reduced Fecal Escherichia coli Levels
• Reduced Fecal Ammonia Levels
• Increased Treatment Responders
• Reduced Incidence of Constipation
• Absence of Adverse Events
• Reduced Crying Time
• No Change in Weight Gain
• Reduced Infant Colics
• Reduced Crying Time in Infants with Colic
• No Adverse Events from Supplementation
• Improved Colic Symptoms
• Increased Number of Responders with Reduced Crying Time
• Improved Response Rate
• Unchanged Stool Frequency
• Weight Gain Consistency

6 Insights on

• Reduced Risk of Common Cold Infections
• Reduced Duration of Common Cold Symptoms
• Reduced Total Symptom Score
• Reduced Pharyngeal Symptoms
• Reduced B Lymphocyte Proliferation
• Reduced Risk of Common Cold

3 Insights on

• Improved Atopic Dermatitis Symptoms
• Reduced Vascular Permeability
• Reduced Ovalbumin-Specific IgE Level

1 Insight on

• Increased Salivary Immunoglobulin A Secretion

9 Insights on

• Improved Insulin Sensitivity
• Improved Insulin Levels
• Reduced Weight Gain
• Improved Cholesterol Levels
• Increased Bifidobacterial Population
• Reduced Body Weight Accumulation
• Improved Total Cholesterol Levels
• Improved Fasting Glucose Levels
• Reduced Epididymal Adipose Tissue

2 Insights on

• Reduced Interleukin-8 Secretion
• Reduced Pathogen Adhesion

6 Insights on

• Reduced Antibiotic-Associated Diarrhea
• Reduced Diarrhea Rate
• Reduced Helicobacter Pylori Treatment-Related Symptoms
• Reduced C. difficile Disease Recurrences
• Effective Treatment of Crohn's Disease
• Treatment Efficacy for Giardiasis

19 Insights on

• Improved Blood Parameters
• Improved Gastric Tolerance
• No Significant Change in Gastrointestinal Symptoms
• Increased Lactobacillus rhamnosus Presence in Stool
• Stable Antibiotic Susceptibility Profiles
• Stable Blood Parameters
• Increased Antibiotic Susceptibility
• Improved Tolerance to Lactobacillus rhamnosus PRSF-L477
• Safety of Probiotic Strain Lactobacillus rhamnosus PRSF-L477
• Normal Blood Parameters
• Presence of Lactobacillus rhamnosus in Feces
• Maintained Antibiotic Susceptibility
• Unchanged Blood Parameters
• Increased Probiotic Levels
• Improved Antibiotic Susceptibility
• Improved Gut Tolerance
• Altered Blood Parameters
• Tolerance to Lactobacillus rhamnosus PRSF-L477
• No Significant Change in Gastrointestinal Tolerance

10 Insights on

• Enhanced Mucosal Immune Response
• Improved Resistance to Foodborne Pathogens
• Enhanced Resistance to Streptococcus Pneumoniae Infection
• Improved Intestinal Resistance to Salmonella Typhimurium
• Reduced Streptococcus pneumoniae in Lung
• Enhanced Resistance to Respiratory Infections
• Neutral Effect on Respiratory Infections Caused by Streptococcus Pneumoniae
• Improved Resistance to Intestinal Pathogens
• Reduced Respiratory Pathogen Load
• Prevention of Bloodstream Pathogen Dissemination

2 Insights on

• Reduced Milk Bacterial Counts
• Improved Mastitis Symptoms